Sanaby Health Acquisition Corp. I

Sanaby Health Acquisition Corp. I

SANBU
Sanaby Health Acquisition Corp. IUS flagNASDAQ Global Market
10.24
USD
+0.05
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Shell Companies
Address
2625 Middlefield Roa Palo Alto CA United States of America 94306
IPO Date
Oct 15, 2021
Business
Sanaby Health Acquisition Corp. I (NASDAQ:SANBU) operates as a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization with one or more businesses, primarily targeting opportunities in the healthcare sector, including digital health, life science tools and services, and innovative therapeutics; it generates no revenues from products or services. Incorporated in Delaware in 2021 and headquartered in Palo Alto, California, the company completed an initial public offering in October 2021, raising $172.5 million through 15 million units at $10 each, with shares and warrants later trading separately under SANB and SANBW. In October 2022, unable to consummate an initial business combination within the required timeframe, Sanaby Health announced its dissolution and liquidation, redeeming all outstanding Class A common shares at approximately $10.22 per share, cancelling public shares effective October 19, 2022, and allowing warrants to expire worthless, with no subsequent merger, acquisition, or operational activity reported.